| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $550 | +26.1% |
| R&D Expense | $167K | -80.6% |
| SG&A Expense | $730K | -22.6% |
| Operating Income | -$5.5M | -4.0% |
| Interest Expense | $752 | — |
| Net Income | -$2.6M | +38.5% |
| EPS (Basic) | -$0.62 | +56.6% |
| EPS (Diluted) | -$0.62 | +56.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $749K | -37.4% |
| Short-term Investments | $3.0M | +1.0% |
| Accounts Receivable | $83 | -59.9% |
| Current Assets | $4.0M | -7.4% |
| Total Assets | $7.2M | +34.0% |
| Current Liabilities | $925K | +46.7% |
| Total Liabilities | $1.1M | +73.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.3M | +2.8% |
| Capital Expenditures | $4K | — |
| Investing Cash Flow | -$244K | -110.9% |
| Financing Cash Flow | $4.5M | +87.6% |
| Free Cash Flow | -$4.3M | — |
| $6.1M |
| -11.3% |